Literature DB >> 6197930

Assay and the levels of 2-5A-synthetase in lymphocytes of patients with viral, bacterial and autoimmune diseases.

C Buffet-Janvresse, H Magard, N Robert, A G Hovanessian.   

Abstract

The level of 2-5A-synthetase in extracts of peripheral blood lymphocytes was estimated by the capacity of the enzyme to synthesize 2-5A in the presence of ATP. The 2-5A was then purified on a small column of DEAE-cellulose. Here we show that under or experimental conditions, the amount of 2-5A formed is proportional to the level of the enzyme. The concentration of 2-5A (nmol of AMP/10(6) lymphocytes) in an assay therefore reflects the level of the enzyme. Enhanced levels of 2-5A synthetase were observed in the lymphocytes of patients with viral and bacterial infections. In most of the cases studied, these enhanced levels of the enzyme decreased during the course of infection parallel to recovery. Thus, the level of 2-5A synthetase may indicate the state of the disease and its evolution during the period of treatment; furthermore, it may be a useful marker in monitoring the return to a normal physiological condition. In addition to patients with viral and bacterial infections, enhanced levels of 2-5A synthetase were observed in patients suffering from autoimmune diseases. In five patients studied here, the enhanced levels of 2-5A synthetase remained high at different periods during the course of the disease. These results suggest the presence of circulating interferon throughout the disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197930     DOI: 10.1016/s0771-050x(83)80090-4

Source DB:  PubMed          Journal:  Ann Immunol (Paris)        ISSN: 0300-4910


  5 in total

1.  Expression of interferon-induced genes in different tissues of mice.

Authors:  A M Flenniken; J Galabru; M N Rutherford; A G Hovanessian; B R Williams
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

2.  Detection of elevated levels of 2-5A synthetase in serum from children with various infectious diseases.

Authors:  H Sugino; I Mitani; M Koike; T Kodama; J Sokawa; H Sawai; K Ishibashi; M Itoh; S Watanabe; Y Sokawa
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

3.  Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.

Authors:  J M Pawlotsky; A G Hovanessian; F Roudot-Thoraval; N Robert; M Bouvier; G Babany; J Duval; D Dhumeaux
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

4.  Alpha-interferon inhibits the expression of heavy chain mu messenger RNA in Daudi cells.

Authors:  E Meurs; A G Hovanessian
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

5.  Identification of 69-kd and 100-kd forms of 2-5A synthetase in interferon-treated human cells by specific monoclonal antibodies.

Authors:  A G Hovanessian; A G Laurent; J Chebath; J Galabru; N Robert; J Svab
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.